Company Filing History:
Years Active: 1977
Title: Douglas E. Lorenz: Innovator in Virus Vaccine Production
Introduction: Douglas E. Lorenz is a notable inventor based in Bethesda, MD, recognized for his pivotal contributions to the field of vaccine development. With a focus on sub-human primate diploid cell lines, his work opens new avenues for the production of effective virus vaccines, showcasing his commitment to advancing medical science.
Latest Patents: Douglas E. Lorenz holds a patent for "Sub-human primate diploid cell lines as substrates for virus vaccine." This patent describes the suitability of monkey diploid cell lines for the production of virus vaccines, detailing methods for culturing these cells effectively. His research provides valuable insights that enhance the vaccine production process.
Career Highlights: Lorenz is affiliated with the United States Government, where he engages in groundbreaking research that has significant implications for public health. His contributions reflect his dedication to innovation within governmental frameworks, marrying scientific research with practical applications.
Collaborations: Throughout his career, Lorenz has worked alongside esteemed colleagues, including John C. Petricciani and Hope E. Hopps. Their collaborative efforts contribute to a robust research environment, fostering innovations that address pressing health challenges and enhance vaccine efficacy.
Conclusion: Douglas E. Lorenz's work in developing sub-human primate diploid cell lines for vaccine production illustrates the critical role of inventors in the biotechnology field. His patent serves as a testament to the continuous effort to improve vaccine manufacturing processes, supporting global health initiatives through scientific innovation.